CVS Health
2,238 hedge funds and large institutions have $82.7B invested in CVS Health in 2023 Q4 according to their latest regulatory filings, with 301 funds opening new positions, 661 increasing their positions, 1,088 reducing their positions, and 126 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,238
Holders Change
+140
Holders Change %
+6.67%
% of All Funds
32.81%
Holding in Top 10
69
Holding in Top 10 Change
+19
Holding in Top 10 Change %
+38%
% of All Funds
1.01%
New
301
Increased
661
Reduced
1,088
Closed
126
Calls
$1.73B
Puts
$1.29B
Net Calls
+$439M
Net Calls Change
+$59.1M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$2.38B |
| 2 |
Capital International Investors
Los Angeles,
California
|
+$856M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$816M |
| 4 |
Dodge & Cox
San Francisco,
California
|
+$291M |
| 5 |
Neuberger Berman Group
New York
|
+$187M |
Top Sellers
| 1 |
Two Sigma Investments
New York
|
-$152M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$147M |
| 3 |
Two Sigma Advisers
New York
|
-$137M |
| 4 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$128M |
| 5 |
Barclays
London,
United Kingdom
|
-$127M |
